drugset / Trial / NCT00271570
Infliximab (Remicade) for Patients With Acute Kawasaki Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.
Timeline
- Start
- 2004-04
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 5 mg/kg | Intravenous |
| Comparator | Intravenous immunoglobulin | Protein / enzyme biologic | 2 g/kg | Intravenous |